Flash Forward is a show about possible (and not so possible) future scenarios. What would the warranty on a sex robot look like? How would diplomacy work if we couldn’t lie? Could there ever be a fecal transplant black market? (Complicated, it wouldn’t, and yes, respectively, in case you’re curious.) Hosted and produced by award winning science journalist Rose Eveleth, each episode combines audio drama and journalism to go deep on potential tomorrows, and uncovers what those futures might re ...
…
continue reading
Content provided by Dr Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!
Go offline with the Player FM app!
Head and Neck Cancer | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Head and Neck Cancer
QUICKTIME•Episode home
Manage episode 421370408 series 1464352
Content provided by Dr Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Featuring perspectives from Ms Meetal Dharia, Dr Robert L Ferris, Dr Robert Haddad and Ms Lynsey P Teulings, including the following topics:
- Introduction (0:00)
- The Biology of Head and Neck Cancer (15:41)
- The Multidisciplinary Treatment of Head and Neck Cancer (18:14)
- Ongoing Screening and Prevention After Potentially Curative Therapy for Head and Neck Cancer (33:03)
- Radiation Therapy and Chemotherapy Side Effects (41:02)
- The Potential Short- and Long-Term Effects of Surgery for Head and Neck Cancer (49:50)
- Emerging Treatment Strategies Aimed at Improving Outcomes Associated with Localized or Locally Advanced Head and Neck Cancer (56:46)
- Tolerability Considerations with Xevinapant (1:06:13)
- The Established Role of Anti-PD-1/PD-L1 Antibodies in Therapy for Advanced Head and Neck Cancer (1:17:35)
- Newly Approved Immunotherapeutic Strategies for Nasopharyngeal Carcinoma (1:19:27)
- The Tolerability of Immune Checkpoint Inhibitors (1:24:09)
1415 episodes
QUICKTIME•Episode home
Manage episode 421370408 series 1464352
Content provided by Dr Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Featuring perspectives from Ms Meetal Dharia, Dr Robert L Ferris, Dr Robert Haddad and Ms Lynsey P Teulings, including the following topics:
- Introduction (0:00)
- The Biology of Head and Neck Cancer (15:41)
- The Multidisciplinary Treatment of Head and Neck Cancer (18:14)
- Ongoing Screening and Prevention After Potentially Curative Therapy for Head and Neck Cancer (33:03)
- Radiation Therapy and Chemotherapy Side Effects (41:02)
- The Potential Short- and Long-Term Effects of Surgery for Head and Neck Cancer (49:50)
- Emerging Treatment Strategies Aimed at Improving Outcomes Associated with Localized or Locally Advanced Head and Neck Cancer (56:46)
- Tolerability Considerations with Xevinapant (1:06:13)
- The Established Role of Anti-PD-1/PD-L1 Antibodies in Therapy for Advanced Head and Neck Cancer (1:17:35)
- Newly Approved Immunotherapeutic Strategies for Nasopharyngeal Carcinoma (1:19:27)
- The Tolerability of Immune Checkpoint Inhibitors (1:24:09)
1415 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.